Günther Laufer

Title: Innovations by Günther Laufer in Pharmaceutical Compositions

Introduction

Günther Laufer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating hyperplastic diseases. With a total of 2 patents, Laufer's work is recognized for its potential impact on medical treatments.

Latest Patents

Laufer's latest patents focus on pharmaceutical compositions that comprise lignans and their derivatives. These compositions are designed for treating hyperplastic diseases, including conditions such as intimal hyperplasia, stenosis, restenosis, and atherosclerosis. One of the preferred compounds in his inventions is leoligin, which is derived from the plant Cass. (Edelweiss). The patents also describe corresponding means and methods for the medical uses of these compounds, including their application in treating proliferative diseases like leukemia, prostate cancer, and lung cancer.

Career Highlights

Günther Laufer is affiliated with the University of Innsbruck, where he continues to advance research in pharmaceutical sciences. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.

Collaborations

Laufer has collaborated with esteemed colleagues such as Hermann Stuppner and Stefan Schwaiger. These partnerships have contributed to the depth and breadth of his research endeavors.

Conclusion

Günther Laufer's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatments for serious health conditions. His work continues to inspire advancements in medical science.